# 2026-19542: Chem Company Seeks Bulk Schedule I Drug Making License

2026-19542, Bulk Manufacturer of Controlled Substances Application: Cayman Chemical Company, is a Federal Register notice from Justice Department, Drug Enforcement Administration published 2026-09-24, effective Registered bulk manufacturers of the affected basic class(es), and applicants, therefore, may submit electronic comments on or objections to the issuance of the proposed registration on or before November 23, 2026. Such persons may also file a written request for a hearing on the application on or before November 23, 2026.; PRIA reads it as touching household money (as of 2026-10-01).

- Canonical: https://policyrisk.com/federal-register/2026-19542
- As of: 2026-10-01
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2026-19542
- Title: Bulk Manufacturer of Controlled Substances Application: Cayman Chemical Company
- Type: Notice
- Agencies: Justice Department; Drug Enforcement Administration
- Citation: 91 FR 60650
- Published: 2026-09-24
- Effective: Registered bulk manufacturers of the affected basic class(es), and applicants, therefore, may submit electronic comments on or objections to the issuance of the proposed registration on or before November 23, 2026. Such persons may also file a written request for a hearing on the application on or before November 23, 2026.
- Comments close: 2026-11-23
- Significant: no
- Touches household money: yes
- Regulation identifier numbers: none
- Last updated: 2026-10-01

## In one line

Chem Company Seeks Bulk Schedule I Drug Making License

## Summary

Cayman Chemical Company wants to become an official bulk maker of some powerful controlled substances, mostly in Schedule I. This means they’ll be able to produce these drugs in large amounts for research or medical use. If you have thoughts or objections, you’ve got until November 23, 2026, to speak up online—no fees or money changes yet, just a chance to weigh in!

## Abstract

Cayman Chemical Company has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

## Effects PRIA read

- Public comment and hearing deadline: benefit, low. The notice gives registered bulk manufacturers and applicants until November 23, 2026 to submit electronic comments or to file a written request for a hearing about Cayman Chemical Company’s application. Comments must be submitted through https://www.regulations.gov and you will receive a Comment T…
- Application to bulk manufacture many controlled substances: benefit, medium. On August 5, 2026, Cayman Chemical Company (1180 East Ellsworth Road, Ann Arbor, Michigan) applied to be registered to bulk manufacture a long list of controlled substances in Schedules I and II. The company says it plans to bulk manufacture these substances for forensic purposes, to produce analyt…
- Synthetic marijuana / THC production limited: benefit, low. For drug codes 7360 (Marihuana) and 7370 (Tetrahydrocannabinols), Cayman Chemical Company states it plans to bulk manufacture these drugs as synthetic products. The notice says no other activities for these specific drug codes are authorized for this registration.

## Related documents

- [2026-11526](https://policyrisk.com/federal-register/2026-11526): Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 201…, 2026-06-09
- [2026-10128](https://policyrisk.com/federal-register/2026-10128): Revision of Applications for Manufacturing and Procurement Quotas, 2026-05-20
- [2025-05007](https://policyrisk.com/federal-register/2025-05007): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-03-24
- [2025-02793](https://policyrisk.com/federal-register/2025-02793): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-02-19
- [2026-20749](https://policyrisk.com/federal-register/2026-20749): Vladimir Romaniv, P.A.; Decision and Order, 2026-10-09
- [2026-20750](https://policyrisk.com/federal-register/2026-20750): L Krenk DBA Maui Clinic Pharmacy; Decision and Order, 2026-10-09

## Sources
- [2026-19542 on federalregister.gov](https://www.federalregister.gov/documents/2026/09/24/2026-19542/bulk-manufacturer-of-controlled-substances-application-cayman-chemical-company)
- [2026-19542 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2026-09-24/pdf/2026-19542.pdf)

## Related
- [Previous: 2026-19541, Bulk Manufacturer of Controlled Substances Application: Eli-Elsohly Laboratories](https://policyrisk.com/federal-register/2026-19541)
- [Next: 2026-19543, Certain Boiler Protection for Absorption Refrigeration Systems and Components T…](https://policyrisk.com/federal-register/2026-19543)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2026-19542 (as of 2026-10-01).